InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$222.66

2026-10-16

Market Cap

$21.7B

Volume

0.6M

52-Wk High

$269.44

52-Wk Low

$195.14

Trailing PE

27.2

P/S

3.60

Gross Margin

44.4%

Net Margin

13.3%

ROE

11%

ROIC

9%

Piotroski

8/9

Altman Z

5.2

1-Yr Return

-7.1%

5-Yr Return

+56.5%

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.

SectorHealthcareIndustryMedical - SpecialtiesExchangeNYSEMarket Cap$21.7BEmployees17,937 (SEC-filed)CEODaniel A. CarestioIPO1992-06-01CountryUS

5960 Heisley Road, Mentor, OH 44060 · Tel 353 1 232 2000 · steris.com

INSIDERSTREET SCORE69 / 100Street mean $275.00 (1 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$3M sold / 6 mo, zero open-market buys

INSIDERSTREET
SCORE69of 100

Score Breakdown

Profitability	53/100
Growth	63/100
Momentum	90/100
Quality	81/100
Earnings Quality	74/100
Balance Sheet	72/100
Value	51/100
Risk (safety)	100/100
Overall	68.5/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
ALC	46
THC	63
VTRS	37
GH	42
INSM	49
GMAB	40
STE	69

IS Score Trend — quarterly

17 quarters, 23 Q1 to 27 Q1. Peak 72 in 26 Q2, latest 69 — -4 since. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

1 Year vs S&P 500 · STE -7.1% · S&P 500 +15.9% · spread -23.0pp

7 Years vs S&P 500 · STE +56.5% · S&P 500 +189.9% · spread -133.3pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

BUSINESS QUALITY69 / 100IS Score 68.5 / 100 · -3.8 from peak of 72

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 80 / 100 · Power +60 · 19 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 69 and price structure at 80 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 68.5	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 72 → 71 → 72 → 69	the direction matters more than the level
Technical vote share back above 50%	now 82%	price structure no longer broken

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score2 of 4top 13% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)12 buys2026-09-11

Insider Buys (180d)0none disclosed

ETF Funds (30d)1000 up / 822 downnet +178 funds

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Burton Karen L	Sr. Vice Pres., CFO	2026-10-01	TAX W/H	228	—	12,956
Sohi Mohsen	director	2026-08-12	EXERCISE	4,058	$0.35M	28,363
Sohi Mohsen	director	2026-08-12	SELL	4,058	$0.96M	24,305
Sohi Mohsen	director	2026-08-12	EXERCISE	4,058	$0.35M	0
Boulud Pierre	director	2026-08-10	A-Award	1,025	—	1,392
Alegria Esther M.	director	2026-08-10	A-Award	1,506	$0.36M	1,506
Alegria Esther M.	director	2026-08-10	A-Award	512	—	3,408
Sohi Mohsen	director	2026-08-10	A-Award	1,099	$0.26M	1,099

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	6	14,484	$3.2M	Counted
M — Exercises (paired A/D)	4	14,718	$1.4M	None — mechanics
F — Tax withholding	24	11,890	$2.5M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$3.2M6 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-08-18	Breeden Richard C	4,110	$1.0M
2026-08-12	Sohi Mohsen	4,058	$1.0M
2026-06-15	Zangerle John Adam	1,419	$0.3M
2026-06-05	Carestio Daniel A	1,374	$0.3M
Trailing 12 mo	11 filings	43,797	$11M

Filed	Form	Reporting person	% of class	Shares
2026-05-12	SCHEDULE 13G	STATE STREET CORPORATION	5.10%	5.0M sh
2026-04-29	SCHEDULE 13G	Vanguard Portfolio Management	5.05%	5.0M sh
2026-03-27	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2025-11-04	SCHEDULE 13G/A	Massachusetts Financial Services Company	4.90%	4.8M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-25	2026-10-09
Kevin Hern	House	SELL	$15,001 - $50,000	2026-09-15	2026-09-28
Kevin Hern	House	SELL	$15,001 - $50,000	2026-09-15	2026-09-25
Susan M. Collins	Senate	SELL	$1,001 - $15,000	2014-07-23	2015-07-20
Susan M. Collins	Senate	SELL	$1,001 - $15,000	2014-07-23	2015-07-19
Susan M. Collins	Senate	SELL	$1,001 - $15,000	2014-07-23	2014-08-14

House 12-Mo44 trades24 purchases

Senate 12-Mo0 tradesNone purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)1,364

13F Shares93M94.5% of shares out

New / Closed67 / 571positions, QoQ

Increased / Reduced369 / 272positions, QoQ

Put/Call (13F)1.22option positions

Free Float99.7%97M sh

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.0%	$649M
VTI	0.0%	$649M
VSMPX	0.0%	$649M
VTSAX	0.0%	$649M
VFFSX	0.0%	$538M
VOO	0.0%	$538M

13F Filers Holding STE — quarterly

Institutional Put/Call — quarterly

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session42.5%2026-10-15

20-Day Avg59.0%50-day 64.6%

TrendFalling20d vs 50d

By Market CenterQ: 41% · N: 62% · B: 35%latest session

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Weekly Notional ($B)

Where STE Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	1.2M	32 sh
Ubsa Ubs Ats	1.0M	45 sh
Sgmt Sigma X2	0.7M	29 sh
Ebxl Level Ats	0.6M	22 sh
Mstx Ms Trajectory Cross (Ats-1)	0.5M	18 sh
Mlix Instinct X	0.4M	43 sh

Where a dollar of STERIS plc revenue goes. All values FY2026 filings, live.

Region	Revenue	Share
UNITED STATES	$4.3B	73%
Other foreign locations	$1.5B	25%
IRELAND	$108M	2%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

STE (live moat model)Peer median: ALC · THC · VTRS · GH · INSM

Component scores from the live moat model. Peer median illustrative.

Moat score 58/100 — Narrow; primary source Efficient Scale.

3.8 · Employees (SEC filings)

Officer	Title
Daniel A. Carestio	President, Chief Executive Officer & Director
Andrew Xilas	Senior Vice President & GM of Dental
John Adam Zangerle	Senior Vice President, General Counsel & Secretary
Karen L. Burton	Senior Vice President, Chief Financial Officer & Chief Accounting Officer

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)4 of 6recent quarters

Avg Surprise+2.9%

Next Report2026-11-04

Income Quality1.59OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY22	FY23	FY24	FY25	FY26
Revenue	+35.9%	+7.4%	+13.3%	+6.2%	+8.7%
Gross profit	+40.2%	+5.2%	+12.0%	+8.3%	+9.3%
Operating income	-12.9%	+65.6%	+5.7%	+3.7%	+27.1%
Net income	-38.6%	-56.1%	+253.4%	+62.5%	+27.7%

$B · FY ends	FY22	FY23	FY24	FY25	FY26
Revenue	4.2	4.5	5.1	5.5	5.9
Cost of revenue	2.3	2.6	2.9	3.1	3.3
Gross profit	1.9	2.0	2.2	2.4	2.6
R&D expense	0.1	0.1	0.1	0.1	0.1
SG&A expense	1.3	1.1	1.3	1.3	1.4
Operating income	0.5	0.8	0.8	0.9	1.1
EBITDA	1.0	1.3	1.4	1.4	1.6
D&A	0.6	0.6	0.6	0.5	0.5
Pretax income	0.4	0.7	0.7	0.8	1.0
Income tax	0.1	0.1	0.1	0.2	0.3
Net income	0.2	0.1	0.4	0.6	0.8
Diluted EPS ($)	2.48	1.07	3.81	6.20	7.93
Diluted shares (M)	98	100	99	99	99

Operating CF$1B

CapEx$0B

Free cash flow$1B

SBC$0B

Buybacks$0B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY23	FY24	FY25	FY26
Cash & equivalents	0.2	0.2	0.2	0.4
ST investments	0.0	0.0	0.0	0.0
Receivables (net)	0.9	1.0	1.0	1.1
Total current assets	2.0	2.9	2.0	2.4
PP&E (net)	1.8	1.9	2.1	2.3
Goodwill + intangibles	6.0	6.2	6.0	5.8
Total assets	10.8	11.1	10.1	10.7
Accounts payable	0.3	0.3	0.3	0.3
Short-term debt	0.1	0.1	0.1	0.2
Deferred revenue	0.1	0.1	0.1	0.1
Total current liabilities	0.9	0.9	1.0	1.1
Long-term debt	3.0	3.1	1.9	1.8
Total liabilities	4.7	4.7	3.5	3.5
Shareholders' equity	6.1	6.3	6.6	7.2

Cash Flow Statement — Full

$B	FY23	FY24	FY25	FY26
Net income	0.1	0.4	0.6	0.8
D&A	0.6	0.6	0.5	0.5
Stock-based compensation	0.0	0.1	0.1	0.1
Working capital change	(0.3)	(0.1)	0.1	0.0
Operating cash flow	0.8	1.0	1.1	1.3
Capital expenditures	(0.4)	(0.4)	(0.4)	(0.4)
Investing cash flow	(0.4)	(0.9)	0.4	(0.5)
Buybacks	(0.3)	(0.0)	(0.2)	(0.2)
Dividends paid	(0.2)	(0.2)	(0.2)	(0.2)
Debt issuance / (repay)	(0.0)	0.1	(1.2)	(0.1)
Financing cash flow	(0.5)	(0.1)	(1.6)	(0.6)
Free cash flow	0.4	0.6	0.8	1.0

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY22	FY23	FY24	FY25	FY26	TTM
PROFITABILITY
ROE	4.7%	1.7%	6.1%	9.5%	11.3%	11%
ROA	2.7%	1.0%	3.5%	5.8%	7.5%	7.5%
ROIC	3.5%	2.0%	7.1%	7.7%	9.4%	8.7%
Gross margin	44.6%	43.7%	43.2%	44.0%	44.2%	44.4%
Operating margin	11.3%	17.4%	16.3%	15.9%	18.6%	18.9%
Net margin	5.8%	2.4%	7.4%	11.3%	13.2%	13.3%
EBITDA margin	23.9%	29.6%	27.5%	24.9%	26.9%	27.0%
FCF margin	8.7%	8.0%	12.7%	14.3%	16.4%	—
VALUATION
P/E	96.35	173.26	57.75	36.15	27.81	27.2
P/B	3.60	3.05	3.47	3.36	3.03	3.0
P/S	5.12	3.74	4.52	4.07	3.67	3.60
P/FCF	59.15	46.95	35.63	28.56	22.38	23.5
EV/EBITDA	27.61	26.29	17.41	17.85	14.71	14.3
EV/Revenue	5.76	4.35	5.17	4.44	3.94	3.9
Earnings yield	1.0%	0.6%	1.7%	2.8%	3.6%	3.70%
FCF yield	1.7%	2.1%	2.8%	3.5%	4.5%	4.26%

Ratio	FY22	FY23	FY24	FY25	FY26	TTM
LEVERAGE & SOLVENCY
Current ratio	2.04	2.33	3.08	1.96	2.09	1.91
Quick ratio	1.41	1.63	2.36	1.39	1.54	1.35
Debt / equity	0.50	0.53	0.54	0.33	0.29	0.28
Debt / assets	28.7%	30.0%	30.6%	21.7%	19.4%	19.0%
Net debt / EBITDA	3.06	3.70	2.21	1.49	1.04	0.96
Interest coverage	4.51	2.42	6.04	10.23	18.20	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY22	FY23	FY24	FY25	FY26	TTM
EFFICIENCY
Asset turnover	0.51	0.45	0.44	0.51	0.57	0.56
Receivables turnover	6.51	5.96	5.16	5.32	5.56	6.0
DSO (days)	56	61	71	69	66	61
DPO (days)	27	32	34	32	34	37
Cash conversion cycle	92	106	121	112	98	101
GROWTH (YoY)
Revenue growth	47.5%	8.1%	-2.5%	12.9%	8.7%	—
Net income growth	-38.4%	-56.1%	253.4%	62.5%	27.3%	—
EPS growth	-47.4%	-55.6%	256.0%	62.7%	27.8%	—
FCF growth	-11.8%	-0.6%	55.2%	26.9%	25.0%	—
PER SHARE ($)
EPS (diluted, TTM)	2.42	1.07	3.83	6.22	7.95	8.25
Book value / share	64.81	61.04	63.75	66.87	73.00	73.99
Revenue / share	45.49	49.79	48.92	55.28	60.32	61.86
FCF / share	3.94	3.97	6.20	7.88	9.88	9.48
Cash / share	3.46	2.09	2.09	1.74	4.47	4.94
SHAREHOLDER RETURN & SCORES
Buyback yield	0.2%	1.7%	0.1%	1.0%	1.1%	1.65%
Altman Z-Score	3.75	3.26	3.93	5.06	5.11	5.2
Piotroski F-Score	5	6	6	8	9	8/9
Beneish M-Score	-2.30	-2.60	-2.43	-2.80	-2.69	-2.47

Model	Score	Zone	Note
Piotroski F-Score	8 / 9	Strong
Altman Z-Score	5.2	Safe (>2.99)	Safe
Income quality	1.59	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.47	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.74
Interest burden	0.96
Operating margin	18.9%
Asset turnover	0.57×
Financial leverage	1.49×
= ROE	11%

Growth Quality (live)	Value
Revenue stability	0.94
Earnings stability	0.63
Earnings persistence	0.90
Revenue CAGR 3y	6.6%
EPS CAGR 3y	89.8%
FCF CAGR 3y	23.3%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield1.65%

Dividend Yield1.16%

Total Shareholder Return2.73%cash yield

SBC / Revenue1.0%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
ALC	$32.0B	50.9	3%	0.0%	+7.8%	6/9	-12.2%
THC	$21.5B	10.2	53%	14.7%	+5.4%	7/9	+34.2%
VTRS	$21.4B	-51.8	-3%	-3.2%	+4.4%	7/9	+87.0%
GH	$21.3B	-45.4	172%	-35.9%	+42.7%	6/9	+135.1%
INSM	$21.0B	-23.4	-87%	-3.1%	+185.8%	5/9	—
GMAB	$22.8B	29.3	4%	26.2%	-77.7%	4/9	—
UTHR	$22.9B	17.6	19%	42.5%	+2.5%	6/9	—
INCY	$22.9B	13.9	31%	35.0%	+26.9%	8/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Buy

14 Analysts

Str Sell (0)Sell (0)Hold (2)Buy (12)Str Buy (0)

Mean Target (qtr)$275.001 targets

Target vs. Price+23.5%last-quarter mean

Next Report2026-11-04street $2.68

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$5.94B	$5.95B / $5.92B	$10.20	$10.21 / $10.19	5
FY2027	$6.38B	$6.40B / $6.35B	$11.21	$11.34 / $10.98	5
FY2028	$6.78B	$6.81B / $6.75B	$12.25	$12.28 / $12.23	5

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Quarter	$275.00	+23.5%	1
Last Year	$271.33	+21.9%	3
All Time	$258.43	+16.1%	7

Rolling mean of published targets vs. last close $222.66. Aggregated from StreetInsider.

Third-Party Composite Rating

B+

DCF

5/5

ROE

3/5

ROA

5/5

Debt/Eq

2/5

P/E

2/5

P/B

2/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

STE -7.1% vs S&P 500 +15.9% — spread -23.0pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$212.43	+10.23	+4.82%	Above
SMA 50	$221.22	+1.44	+0.65%	Above
SMA 200	$226.08	-3.42	-1.51%	Below
EMA 9	$217.55	+5.11	+2.35%	Above
EMA 21	$215.45	+7.21	+3.35%	Above
EMA 50	$217.31	+5.35	+2.46%	Above
EMA 200	$224.02	-1.36	-0.61%	Below

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

TECHNICAL VERDICTBULLISHPower Score +6019 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%80

Momentum 25%91

Volume 20%88

Volatility 10%100

Patterns 15%38

This Week82% bullishof 11 price-based votes

4 Weeks Ago0%+82 pts since

12 Weeks Ago18%+64 pts since

ReadImprovingweek-over-week trajectory

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Price vs SMA 20$212.43

Price vs SMA 50$221.22

Price vs SMA 200$226.08

EMA 9/21 Cross217.6/215.4

SMA 50/200Death

ADX DirectionADX 26

Supertrend$209

Parabolic SAR$211

SMA Slope0.880

RSI62.1

Stochastic K/D84/81

StochRSI K/D91/91

Williams %R-20

CCI189

TSI vs Signal4.7

CMO24.2

ROC6.77%

OBV SignalAccum

Chaikin MF0.220

MFI64

Force Index1M

Elder Ray Bull11.23

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 81

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$222.61 / $226.23 / $228.12	S1 / S2	$220.72 / $217.10
Bollinger (20,2)	$202.61 – $222.24	Squeeze	Off
52-wk range	$195.14 – $268.76	Off 52-wk high	-17.2%
ATR (14)	$4.79 (2.2%)	Historical vol	17.3%

+0.8%Jan60%

+0.3%Feb50%

+2.2%Mar76%

-0.1%Apr45%

+4.0%May70%

+0.9%Jun50%

+2.2%Jul70%

+0.8%Aug55%

+0.4%Sep60%

+2.2%Oct60%

+2.0%Nov70%

-0.5%Dec50%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	STE	S&P 500
Weekly volatility (σ, 1y)	3.78%	1.83%
Best / worst week (1y)	+11.5% / -11.0%	—
Max drawdown (5y, monthly)	-34.1%	—
1-week VaR (95%)	-7.6%	—
Beta (5y)	0.91	1.00

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

STE EQUITY WEATHER (LIVE)PARTLY CLOUDY · +16

Trend+22

Momentum+50

Volume+45

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 85 stories, weekly buckets, −1 to +1.

Overall+16.3+39.0 vs industry

Trend+22.4+52.5 vs industry

Momentum+50.2+78.7 vs industry

Volume+45.4+40.9 vs industry

Reading	STE	Medical - Specialties n=176	Healthcare n=5,272	All US symbols n=70,435
Overall	+16.3	-22.7	-24.0	-20.5
Trend	+22.4	-30.1	-25.6	-21.3
Momentum	+50.2	-28.5	-28.5	-15.8
Volume	+45.4	+4.5	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Daniel A. Carestio President and CEO	$11.5M	53% equity+incentive
Karen L. Burton Senior Vice President and Ch	$3.2M	48% equity+incentive
J. Adam Zangerle Senior Vice President, Gene	$3.0M	49% equity+incentive
Cary L. Majors Senior Vice President and Pre	$2.5M	48% equity+incentive
Michael J. Tokich Senior Financial Advisor	$2.2M	52% equity+incentive

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Pillar (live disclosure scores)	Score
Environmental	67
Social	59
Governance	69
Composite ESG	65

Composite ESG Trend

Filed	8-K contents	Items
2026-10-13	Material Agreement	1.01
2026-08-06	Officer/Director Change	5.02
2026-08-06	Shareholder Vote	5.07
2026-08-05	Earnings Release; Exit/Disposal Costs; Exhibits	2.02,2.05,9.01
2026-05-07	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01
2026-04-06	Officer/Director Change	5.02
2026-02-04	Results of Operations and Financial Condition; Financial Statements an	2.02,9.01
2025-11-05	Results of Operations and Financial Condition; Financial Statements an	2.02,9.01

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2021 to 2026
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-11-02 to 2026-08-05
Analyst estimates	dim/forward_estimates	3 rows · 2026-03-31 to 2028-03-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	28 rows · 2019 to 2025
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-08-10 to 2026-10-01
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2025-11-04 to 2026-05-12
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

STERIS plc (STE)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

STERIS plc (STE)

STERIS plc (STE)

Monthly Net Insider Flow (000 shares)

Signal Summary

STERIS plc (STE)

2.9 · Top ETF & Fund Ownership

13F Filers Holding STE — quarterly

Institutional Put/Call — quarterly

STERIS plc (STE)

Where STE Trades in the Dark

STERIS plc (STE)

3.8 · Employees (SEC filings)

STERIS plc (STE)

STERIS plc (STE)

STERIS plc (STE)

Balance Sheet — Full

Cash Flow Statement — Full

STERIS plc (STE)

STERIS plc (STE)

STERIS plc (STE)

Street Price Target — Trajectory

Third-Party Composite Rating

STERIS plc (STE)

STERIS plc (STE)

Family Scores (site weights)

STERIS plc (STE)

STERIS plc (STE)

STERIS plc (STE)

STERIS plc (STE)